TMT dataset profiling longitudinally-collected CSF from SOD1-ALS subjects who received either tofersen (SOD1-ASO) or placebo treatments during the Phase 3 VALOR clinical trial (NCT02623699)
[doi:10.25345/C5TQ5RS2G]
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: amyotrophic lateral sclerosis (ALS) ; cerebrospinal fluid (CSF) proteomics ; pharmacodynamic-response ; biomarkers ; human clinical trial ; DatasetType:Proteomics
|
Principal Investigators: (in alphabetical order) |
Amanda Guise, Biogen, United States Danielle Graham, Biogen, United States |
| Submitting User: | aguise |
| Number of Files: | |
| Total Size: | |
| Spectra: | |
| Subscribers: | |
| Owner | Reanalyses | |
|---|---|---|
| Experimental Design | ||
|
Conditions:
|
||
|
Biological Replicates:
|
||
|
Technical Replicates:
|
||
| Identification Results | ||
|
Proteins (Human, Remapped):
|
||
|
Proteins (Reported):
|
||
|
Peptides:
|
||
|
Variant Peptides:
|
||
|
PSMs:
|
||
| Quantification Results | ||
|
Differential Proteins:
|
||
|
Quantified Proteins:
|
||
| Browse Dataset Files | |
|
FTP Download Link (click to copy):
|